Connect Biopharma Limited (CNTB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Connect Biopharma Limite...

    NASDAQ: CNTB · Real-Time Price · USD
    1.49
    0.10 (7.19%)
    At close: Oct 03, 2025, 3:59 PM
    1.50
    0.67%
    After-hours: Oct 03, 2025, 07:16 PM EDT

    Connect Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 1.96M 26.03M 24.12M n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 183.53K 183.53K 481.87K 988K 1.03M 1.03M 915.39K 633.44K 221.39K
    Gross Profit
    		 1.78M 25.37M 23.16M -988K -1.03M -1.03M -915.39K -633.44K -221.39K
    Operating Income
    		 -38.33M -17.6M -19.92M -62.07M -89.13M -117.66M -121.64M -99.35M -41.11M
    Interest Income
    		 4.65M 4.85M -1.67M 5.2K 3.79M 1.56M 271.15K 77.81 398.24
    Pretax Income
    		 -35.9M -15.35M -21.16M -59.38M -87.01M -116.12M -116.01M -202.1M -145.82M
    Net Income
    		 -36.12M -15.57M -21.27M -59.5M -87.26M -116.42M -116.39M -202.36M -145.82M
    Selling & General & Admin
    		 16.5M 19.23M 13.35M 13.53M 16.76M 20.37M 22.38M 18.36M 7.2M
    Research & Development
    		 24.67M 29.22M 38.5M 51.91M 71.33M 95.26M 97.34M 80.35M 33.69M
    Other Expenses
    		 -1.07M -5M -8.29M -4.35M n/a -940.31K -940.31K n/a n/a
    Operating Expenses
    		 40.11M 43.44M 44.54M 62.07M 88.09M 114.69M 118.78M 98.72M 40.97M
    Interest Expense
    		 -20K n/a 9.61K n/a 22.7K 21.03K 8.72K n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a 5.94M 13.51M 16.7M n/a 2.04M 18.35M 7.19M
    Cost & Expenses
    		 40.29M 43.63M 44.04M 62.07M 89.13M 114.69M 118.66M 99.35M 41.2M
    Income Tax Expense
    		 217.58K 222.58K 115.22K 120K 250.95K 297.52K 375.21K 263.87K n/a
    Shares Outstanding (Basic)
    		 55.5M 55.19M 55.14M 55.07M 55.05M 55.02M 55.02M 53.74M 46.94M
    Shares Outstanding (Diluted)
    		 55.5M 55.19M 55.55M 55.07M 55.05M 55.02M 55.02M 53.74M 46.94M
    EPS (Basic)
    		 -0.65 -0.28 -0.38 -1.08 -1.59 -14.5 -14.52 -4.15 -3.1
    EPS (Diluted)
    		 -0.65 -0.28 -0.38 -1.08 -1.59 -14.5 -14.52 -4.15 -3.1
    EBITDA
    		 -36.12M -14.68M -20.18M -58.37M -83.76M -111.31M -115.4M -98.72M -60.4M
    EBIT
    		 -36.48M -15.34M -21.14M -59.36M -86.99M -118.04M -117.95M -76.96M -40.23M
    Depreciation & Amortization
    		 354.53K 659.53K 957.87K 988K 1.03M 1.01M 898.39K 633.44K 221.51K

    Add to Watchlist